Dow Down 0.26% Nasdaq Up 0.07%

ACADIA Pharmaceuticals Inc. (ACAD)

-NasdaqGS
26.11 Up 2.13(8.88%) 12:01PM EDT - Nasdaq Real Time Price
Prev Close:23.98
Open:26.76
Bid:26.27 x 100
Ask:26.31 x 200
1y Target Est:33.60
Beta:2.75
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:25.20 - 26.98
52wk Range:15.64 - 32.00
Volume:3,559,348
Avg Vol (3m):989,342
Market Cap:2.60B
P/E (ttm):N/A
EPS (ttm):-0.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACAD

Comparison

Symbol% ChgMkt Cap
ACADUp 8.88%2.60B
AZNDown 1.57%94.49B
LLYUp 0.13%68.20B
PFEDown 0.34%185.72B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7,117.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.86
Quarterly EPS Est (Sep-14) :-0.22
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.39

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback